Responses
Scientific Abstracts
Poster Presentations
Posters
Bone diseases other than osteoporosis, metabolic diseases and crystal diseases
FRI0372 Pharmacokinetics and immunogenicity of pegloticase (PL) infused every 3 weeks to treat refractory gout (RG), including in organ transplant recipients (TR)
Compose a Response to This Article
Other responses
No responses have been published for this article.